Eligibility
Applicant type, geography, program rules and required conditions.
My Organization Fit Score
See how strongly this opportunity fits your organization.
Atlas combines public grant intelligence with the details of your organization to evaluate eligibility, strategic alignment, funding potential, timing, project fit and submission burden.
GrantNIH/NCCIH | Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (PAR-25-268)
Atlas Opportunity Score86/100
FundingApplication budgets are not limited but must reflect actual project needs; maximum project period is five years.
DeadlineOctober 20, 2026 at 5:00 PM local time of the applicant organization.
Required next actionEligible applicant organizations should confirm scientific fit with PAR-25-268, assemble an experienced remote or mHealth clinical-trial team, ensure SAM, Grants.gov, and eRA Commons registrations are active, follow the NIH application instructions, and submit by October 20, 2026 at 5:00 PM local time of the applicant organization.
Current statusActive — next application deadline October 20, 2026 at 5:00 PM local applicant timeSource verificationOctober 7, 2026
Tell Atlas Who You Are
Request your organization-specific analysis.
The form will carry the grant context with it, so you only need to provide the details Atlas cannot know from the opportunity itself.
How Atlas Scores Fit
Useful enough to guide action, structured enough to scale.
Strategic Alignment
How directly the organization's goals and use case match the funder's priorities.
Funding Potential
Available dollars, allowable uses, match burden and the amount that can realistically support the project.
Actionability
Deadline, documentation burden, readiness and the practical work required to submit a strong application.
A High Score Is the Beginning
When the fit is strong, Atlas shows you why.
The goal is not to hand you another number. It is to identify the opportunities worth your attention and make the next step obvious.